Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.86 is 18% below its 5-year average of 3.50, near the low end of its 5-year range (2.09–7.87).
As of the fiscal period ended Tuesday, June 30, 2026. 1.61% above its 12-month average of 2.81.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.86.
CURRENT RATIO
2.86
CURRENT RATIO AVG TTM
2.81
CURRENT RATIO AVG 3Y
3.30
CURRENT RATIO AVG 5Y
3.50
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+1.61%
CURRENT VS 3Y AVG
-13.54%
CURRENT VS 5Y AVG
-18.47%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.67
median of 820 covered companies
CURRENT VS SECTOR MEDIAN
-22.28%
vs the sector median at left
Mirum Pharmaceuticals, Inc.
Market Cap
$4.80B
Current Ratio
2.86
TTM Avg
2.81
3Y Avg
3.30
5Y Avg
3.50
Market Cap
$4.77B
Current Ratio
38.51
TTM Avg
25.63
3Y Avg
37.00
5Y Avg
29.64
Market Cap
$4.69B
Current Ratio
1.38
TTM Avg
1.51
3Y Avg
1.37
5Y Avg
1.46
Market Cap
$4.67B
Current Ratio
26.10
TTM Avg
14.27
3Y Avg
14.23
5Y Avg
14.47
Market Cap
$4.66B
Current Ratio
6.95
TTM Avg
6.77
3Y Avg
6.23
5Y Avg
10.87
Market Cap
$5.06B
Current Ratio
7.02
TTM Avg
8.28
3Y Avg
8.59
5Y Avg
7.77
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | $4.80B | 2.86 | 2.81 | 3.30 | 3.50 |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.77B | 38.51 | 25.63 | 37.00 | 29.64 |
| LifeStance Health Group, Inc. (LFST)vs › | $4.69B | 1.38 | 1.51 | 1.37 | 1.46 |
| BillionToOne, Inc. (BLLN)vs › | $4.67B | 11.69 | 9.86 | 7.15 | 7.15 |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.67B | 26.10 | 14.27 | 14.23 | 14.47 |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.66B | 6.95 | 6.77 | 6.23 | 10.87 |
| Option Care Health, Inc. (OPCH)vs › | $4.66B | 1.47 | 1.61 | 1.69 | 1.64 |
| Erasca, Inc. (ERAS)vs › | $5.00B | 8.29 | 9.94 | 10.32 | 11.01 |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.06B | 7.02 | 8.28 | 8.59 | 7.77 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.07B | 4.20 | 4.30 | 4.12 | 3.47 |
Current Ratio
2.86
Quick Ratio
2.74
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.86 |
| 2026-03-31 | 2.09 |
| 2025-12-31 | 2.67 |
| 2025-09-30 | 3.31 |
| 2025-06-30 | 3.13 |
| 2025-03-31 | 3.22 |
| 2024-12-31 | 3.10 |
| 2024-09-30 | 3.34 |
| 2024-06-30 | 3.28 |
| 2024-03-31 | 3.68 |
| 2023-12-31 | 4.45 |
| 2023-09-30 | 5.20 |
| 2023-06-30 | 6.59 |
| 2023-03-31 | 3.53 |
| 2022-12-31 | 2.94 |
| 2022-09-30 | 4.19 |
| 2022-06-30 | 3.26 |
| 2022-03-31 | 4.49 |
| 2021-12-31 | 3.91 |
| 2021-09-30 | 3.91 |
| 2021-06-30 | 7.87 |
| 2021-03-31 | 6.22 |
| 2020-12-31 | 12.80 |
| 2020-09-30 | 7.35 |
| 2020-06-30 | 9.17 |
| 2020-03-31 | 11.99 |
| 2019-12-31 | 9.13 |
| 2019-09-30 | 11.85 |
| 2019-06-30 | 7.64 |
| 2019-03-31 | 7.63 |
| 2018-12-31 | 21.22 |
| 2018-09-30 | 0.00 |
